immunotherapy
-
Dendritic Cell-Based Immunotherapy Induces Transient Clinical Response in Advanced Rat Fibrosarcoma – Comparison with Preventive Anti-tumour Vaccination
A. Kučera, K. Pýcha, P. Pajer, Radek Špíšek, R. Škába
2009, Vol. 55, Issue 4, pp. 119-125 -
Immunotherapeutic Efficacy of Vaccines Generated by Fusion of Dendritic Cells and HPV16-Associated Tumour Cells
Jana Šímová, J. Bubeník, J. Bieblová, M. Indrová, T. Jandlová
2005, Vol. 51, Issue 1, pp. 19-24 -
Allogeneic Gene-Modified Tumour Cells in Metastatic Kidney Cancer. Report II
Giancarlo Pizza, C. De Vinci, G. Lo Conte, A. Mazzuca, V. Di Maio, S. Ratini, G. Severini, L. Busutti, A. P. Palareti, A. Gulino, A. Vacca, L. Melchiorri, M. Ferrari, L. Giacomelli, O. R. Baricordi, S. Forzini, R. Capanna
2004, Vol. 50, Issue 6, pp. 175-183 -
Allogeneic Gene-Modified Tumour Cells in Metastatic Kidney Cancer. Preliminary Report
Giancarlo Pizza, C. De Vinci, G. Lo Conte, A. Mazzuca, G. Corrado, D. Menniti, A. Benati, P. Romagnoli, V. Fornarola, L. Busutti, A. Palareti, R. Capanna, V. Di Maio, S. Ratini, A. Gulino, A. Vacca, L. Melchiorri, M. Ferrari, S. Boriani, R. O. Baricordi
2003, Vol. 49, Issue 4, pp. 147-159 -
A Prospective Open-Label Single-Arm Phase II Study of Chimeric Monoclonal Antibody cG250 in Advanced Renal Cell Carcinoma Patients
Zoltan Varga, P. De Mulder, W. Kruit, A. Hegele, R. Hofmann, C. Lamers, S. Warnaar, C. Mala, S. Ullrich, P. Mulders
2003, Vol. 49, Issue 2, pp. 74-77 -
Adjuvant Autologous Tumour Cell-Lysate Vaccine versus No Adjuvant Treatment in Patients with M0 Renal Cell Carcinoma after Radical Nephrectomy: 3-Year Interim Analysis of a German Multicentre Phase-III Trial
Christian Doehn, A. Richter, W. Lehmacher, D. Jocham
2003, Vol. 49, Issue 2, pp. 69-73
